Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Registration - Consultant

Novartis Pharmaceuticals Canada Inc / GERALD JEFFCOTT, Consultant

Registration Information

Client name: Novartis Pharmaceuticals Canada Inc
Lobbyist name: GERALD JEFFCOTT, Consultant
Initial registration start date: 2007-07-05
Registration status: Inactive
Registration Number: 780779-15474

Version 1 of 1 (2007-07-05 to 2008-01-07)

Version 1 of 1 (2007-07-05 to 2008-01-07) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: GERALD D JEFFCOTT    Lobbyist business address
Lobbyist business address: 1602 Westpoprt Crescent
Ottawa, ON  K1C 6C8
Canada
Telephone number: 613-851-1602  
Fax number: 613-841-9201  
 
Former public office holder: Yes
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: Novartis Pharmaceuticals Canada Inc
385 Bouchard Boulevard
Dorval, QC  H9S 1A9
Canada
Telephone number: 902-425-9589
Fax number: 902-425-6406  
 
Client Representative: Shona Kinley
 
The client is a subsidiary of the following parent companies: Novartis Pharma A.G.
CH-4002
Basel
Switzerland

Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Health Canada (HC), Industry Canada, Members of the House of Commons
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health
 

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program Refrom of the Federal/Provincial/Territorial Comon Drug Review (CDR)




Date Modified: